Apple acquires Silicon Valley healthcare startup

As Apple continues to explore business opportunities in healthcare, news broke this morning that the company has acquired Gliimpse, a personal health data startup in Silicon Valley, reports Fast Company.

Gliimpse, which was founded in 2013, has a platform that enables people to collect, personalize and share a picture of their health data.

The acquisition actually closed earlier this year, but Apple didn’t announce it initially. However, it has since confirmed the purchase.

The acquisitions will likely help Apple secure itself into the healthcare market and continue to gain traction in the sector.

To read the entire article, click the link below.

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.